Retatrutide
DP3-R Overview
DP3-R is a synthetic investigational peptide developed as a multi-pathway agonist. It is currently being studied for its potential effects on receptor-mediated signaling, molecular dynamics, and endocrine function in preclinical research models. By activating multiple target receptor subtypes, DP3-R demonstrates broad systemic effects under investigation for their relevance in endocrine and pathway-level research.
Certificate of Analysis
Third-party tested for 99% purity, ID, quantity.
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Our Process
STEP 1
Precision
LyophilizationManufactured in a controlled U.S. facility under strict compounding standards.
STEP 2
Verified Purity
Every batch third-party tested with HPLC and mass spectrometry.
STEP 3
Same-Day Fulfillment
Orders dispatched same-day from our U.S. facility.
History
The development of DP3-R builds on decades of research into peptide signaling science. Early studies with single pathway agonists established their role in downstream signaling and receptor activity. Subsequent research expanded to dual agonist frameworks, paving the way for DP3-R, which uniquely integrates three pathway targets. This multi-agonist design reflects a new direction in peptide research aimed at investigating broader receptor-mediated modulation in preclinical laboratory settings.
DP3-R Structure
Research Findings
DP3-R has been examined in endocrine and systemic models, with studies highlighting its influence on receptor binding kinetics, downstream signaling cascades, lipid pathway dynamics, and integrated endocrine pathways. Research also points to its role in multi-system signaling and pathway characterization in preclinical and laboratory settings.Key Areas of Research:* Endocrine: Receptor binding, signaling, cascades * Pathway: Target subtypes, modulation, dynamics * Vascular: Lipid pathways, hepatic signaling, markers * Systemic: Multi-pathway signaling, resilience, characterization Together, these findings suggest broad experimental potential for DP3-R across endocrine, vascular, and systemic models. By engaging multiple pathway targets, it provides a versatile research platform for studying downstream signaling cascades and integrated molecular responses across diverse biological systems.Jastreboff A.M. et al., New England Journal of Medicine, 2023
